deltatrials
Terminated OBSERVATIONAL NCT05169372

Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil (PET-PSMA)

Sponsor: Astellas Pharma Inc

Conditions Prostate Cancer
Updated 11 times since 2022 Last updated: Feb 19, 2024 Started: May 11, 2022 Primary completion: Jan 19, 2024 Completion: Jan 19, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

LACOG and Astellas decided to end the study due to the great difficulty in finding patients with the desired profile.

Other terminated trials from Astellas Pharma Inc

More terminations from Astellas Pharma Inc

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

This observational or N/A phase trial investigates Prostate Cancer and is currently terminated or withdrawn. Astellas Pharma Inc leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Nov 2022 · 4 months · monthly snapshot~Nov 2022 – ~Mar 2023 · 4 months · monthly snapshot~Mar 2023 – ~Jul 2023 · 4 months · monthly snapshot~Jul 2023 – ~Mar 2024 · 8 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 9 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated

  4. Mar 2024 — Jul 2024 [monthly]

    Terminated

    Status: Recruiting → Terminated

  5. Jul 2023 — Mar 2024 [monthly]

    Recruiting

▶ Show 6 earlier versions

  1. Mar 2023 — Jul 2023 [monthly]

    Recruiting

  2. Nov 2022 — Mar 2023 [monthly]

    Recruiting

  3. Jul 2022 — Nov 2022 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  4. May 2022 — Jul 2022 [monthly]

    Not Yet Recruiting

  5. Mar 2022 — May 2022 [monthly]

    Not Yet Recruiting

  6. Jan 2022 — Mar 2022 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Astellas Pharma Inc
  • Latin American Cooperative Oncology Group
Data source: Latin American Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations